Indication
Iron deficiency anemia
Iron deficiency anemia is a hematologic disorder that develops when the body's iron stores become depleted, compromising normal erythropoiesis and reducing overall hemoglobin concentration. Read more about Iron deficiency anemia
143 drugs 79 manufacturers
Drugs that treat it
Common Iron deficiency anemia therapies.
WEE CARE (iron,carbonyl)
FERAHEME (ferumoxytol)
HIGH POTENCY IRON (ferrous sulfate)
FERROUS SULFATE
FERROUS SULFATE
FERROUS GLUCONATE
IRON (ferrous sulfate)
IRON (ferrous fumarate)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonIron deficiency anemia is a hematologic disorder that develops when the body's iron stores become depleted, compromising normal erythropoiesis and reducing overall hemoglobin concentration.
Commonly affecting infants, young children, pregnant or menstruating individuals, and adults with occult gastrointestinal blood loss or malabsorption syndromes, it impairs systemic oxygen delivery.
Pathophysiologically, the absence of sufficient iron results in the production of microcytic, hypochromic erythrocytes, typically reflected in laboratory evaluations by low serum ferritin, reduced transferrin saturation, and decreased mean corpuscular volume, which clinically manifests as fatigue, pallor, weakness, and exertional dyspnea.
- nih.gov
Iron deficiency anemia is a hematologic disorder that develops when the body's iron stores become depleted, compromising normal erythropoiesis and reducing overall hemoglobin concentration
- nih.gov
Iron deficiency anemia is a hematologic disorder that develops when the body's iron stores become depleted, compromising normal erythropoiesis and reducing overall hemoglobin concentration Pathophysiologically, the absence of sufficient iron results in the production of microcytic, hypochromic erythrocytes, typically reflected in laboratory evaluations by low serum ferritin, reduced transferrin saturation, and decreased mean corpuscular volume, which clinically manifests as fatigue, pallor, weak...
- nih.gov
Commonly affecting infants, young children, pregnant or menstruating individuals, and adults with occult gastrointestinal blood loss or malabsorption syndromes, it impairs systemic oxygen delivery Pathophysiologically, the absence of sufficient iron results in the production of microcytic, hypochromic erythrocytes, typically reflected in laboratory evaluations by low serum ferritin, reduced transferrin saturation, and decreased mean corpuscular volume, which clinically manifests as fatigue, pall...
- nih.gov
Commonly affecting infants, young children, pregnant or menstruating individuals, and adults with occult gastrointestinal blood loss or malabsorption syndromes, it impairs systemic oxygen delivery
- nih.gov
Commonly affecting infants, young children, pregnant or menstruating individuals, and adults with occult gastrointestinal blood loss or malabsorption syndromes, it impairs systemic oxygen delivery
- nih.gov
Commonly affecting infants, young children, pregnant or menstruating individuals, and adults with occult gastrointestinal blood loss or malabsorption syndromes, it impairs systemic oxygen delivery
Personalize your experience
Follow Iron deficiency anemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.